Aktie 566526 NISSUI PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Nissui Pharmaceutical Co., Ltd.

Aktien

566526

JP3678100003

4550

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
MiCAN Technologies Inc. announced that it has received ¥50 million in funding from Nissui Pharmaceutical Co., Ltd.
Nissui Pharmaceutical Co., Ltd.(TSE:4550) dropped from S&P Global BMI Index
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022.
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022.
Nissui Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 31, 2022 has closed with 12,552,248 shares, representing 55.67% for ¥20,861.84
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion.
Nissui Pharmaceutical : Consolidated Financial Results for the Three Months Ended June 30, 2022
Nissui Pharmaceutical Co., Ltd. announces an Equity Buyback for 13,237,063 shares, representing 58.71% for ¥22,000 million.
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion.
Nissui Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Consolidated Financial Results for the Six Months Ended September 30, 2021
Announcement: Transition of distribution in Europe, Turkey and Africa
Nissui Pharmaceutical Co., Ltd. cancelled the acquisition of 10% stake in Nihon Techno Service Co., Ltd. from Takashi Masaki.
Nissui Pharmaceutical : Consolidated Financial Results for the Nine Months Ended December 31, 2020
Zeria Pharmaceutical Co., Ltd. cancelled the agreement to acquire Nissui Pharm Medical Sales Co., Ltd. from Nissui Pharmaceutical Co., Ltd..
Nissui Pharmaceutical Co., Ltd.(TSE:4550) added to S&P Global BMI Index
Nissui Pharmaceutical Co., Ltd. agreed to acquire 10% stake in Nihon Techno Service Co., Ltd. from Takashi Masaki.
Nihon Techno Service Co., Ltd. announced that it has received funding from Nissui Pharmaceutical Co., Ltd.
Zeria Pharmaceutical Co., Ltd. entered into an agreement to acquire Nissui Pharm Medical Sales Co., Ltd. from Nissui Pharmaceutical Co., Ltd. for ¥3.3 billion.
MiCAN Technologies Inc. announced that it has received ¥21.6 million in funding from Nissui Pharmaceutical Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 566526 Aktie
  4. Nachrichten Nissui Pharmaceutical Co., Ltd.
  5. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT